We are determined to contribute to public health and
through our ongoing development of
innovative diagnostic technologies.
- In Vitro Diagnostic Reagents
- We provide high-quality clinical diagnostics reagents for autoimmune diseases and genetic testing, targeted for clinical laboratories and hospitals.
- Customized Companion Diagnostics
- To support drug development, MBL provides contract services for development of companion diagnostics.
Aug 01, 2022MEBGEN™ BRAF Kit Receives MHLW Approval as Companion Diagnostic for Use with Patients with Melanoma
Apr 04, 2022Launch of a New Kit for the Detection of anti-Integrin αvβ6 Antibodies.
Sep 17, 2021MBL established a new R&D and manufacturing site for in-vitro diagnostic products and services in Shenzhen, China
Nov 21, 2022QuickSwitch™ Quant HLA-B*07:02 Tetramer Kits are now available
For customizing MHC class I tetramer. A patented technique allows to exchange peptides on MHC. New allele, HLA-B*07:02, join in the series!!
Aug 03, 2022Trial size products of DDDDK-tagged protein purification kits are now available!
Jun 15, 2022QuickSwitch™ Quant HLA-A*01:01 Tetramer Kits are now available
For customizing MHC class I tetramer. A patented technique allows to exchange peptides on MHC. New allele, HLA-A*01:01, join in the series!!